Hepion Pharmaceuticals, Inc. (HEPA)
OTCMKTS · Delayed Price · Currency is USD
0.0750
0.00 (0.00%)
At close: Aug 17, 2026
Hepion Pharmaceuticals Market Cap
Hepion Pharmaceuticals has a market cap or net worth of $6.65 million as of August 18, 2026. Its market cap has increased by 808.91% in one year.
Market Cap
6.65M
Enterprise Value
6.72M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.08
ChartMarket Cap Chart
Since February 10, 2014, Hepion Pharmaceuticals's market cap has decreased from 13.86M to 6.65M, a decrease of -51.99%. That is a compound annual growth rate of -5.69%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 17, 2026 | 6.65M | 854.36% |
| Dec 31, 2025 | 697.22K | -78.69% |
| Dec 31, 2024 | 3.27M | -76.72% |
| Dec 29, 2023 | 14.05M | -38.61% |
| Dec 30, 2022 | 22.89M | -73.66% |
| Dec 31, 2021 | 86.90M | 23.90% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Zeo ScientifiX | 10.97M |
| Brainstorm Cell Therapeutics | 10.92M |
| Adaptimmune Therapeutics | 7.69M |
| Curative Biotechnology | 6.92M |
| Reviva Pharmaceuticals Holdings | 6.69M |
| TRON Group | 5.70M |
| America Great Health | 4.23M |
| GPL Holdings | 4.20M |